Lucknow Speciality Pharma

Asciminib Tablets 40 mg
Asciminib Tablets is used to treat a certain type of chronic myeloid leukemia (CML; a type of cancer of the white blood cells) as a first treatment and in people who can no longer benefit from other leukemia medications. Asciminib is in a class of medications called kinase inhibitors.Patient Support Number +91-9555306364, 9 am - 8 pm IST or send us a request on email (urgent@lucknowpharma.com) /WhatsApp for the same.
Get The Best Access Price
WhatsApp

Asciminib Tablets was approved for medical use in the United States in 2021. It is on the World Health Organization’s List of Essential Medicines. It is available as a generic medication.

Asciminib Tablets Available Price In Lucknow Banaras Nepal

Asciminib Tablets

  • Generic Brand Available – Scemblix 
  • API – Asciminib
  • Packaging – 60 Tablets
  • Strength – 20 mg, 40 mg

What is Asciminib Tablets used for?

Asciminib Tablet  is used to treat a certain type of chronic myeloid leukemia (CML; a type of cancer of the white blood cells) as a first treatment and in people who can no longer benefit from other leukemia medications. Asciminib is in a class of medications called kinase inhibitors.

    Get Access To Asciminib Tablets 40 mg

    Lucknow Speciality Pharma is a registered Pharmaceutica Firm in Lucknow, India. Registered under GST Act. Registration Number : 09AAOPG3102HIZY. It provide assistance and connectivity with drug pharmacies or distributors for access to genuine medicines at competitive prices. We help through our network for prescription innovator medicine, brand, and generic pharmaceuticals and over-the-counter (OTC) health care products.

    Lucknow Speciality Pharma

    Mobile : 9140551027 / 9794360370
    WhatsApp: +91-9555306364
    E: info@lucknowpharma.com
    Website: www.lucknowpharma.com

    Generic Subsitiute Medicines Available in India

    Breast cancer, Prostate cancer, Skin cancer (melanoma), Colon cancer, Lung cancer, Leukemia, Lymphoma etc

    Generic Subsitiute Medicines Available in India

    Anemia, Diabetes, Hepatitis B & Hepatitis C, HIV,  Asthama, Bone Marrow, Cardiology, Rheumatoid Arthritis, Fungal Disease, Multiple Sclerosis (MS) etc.

    US FDA Approved Imported Medicines Available in India

    Breast cancer, Prostate cancer, Skin cancer (melanoma), Colon cancer, Lung cancer, Leukemia, Lymphoma etc

    Branch Offices in India : Lucknow | Agra | Varanasi | Gorakhpur | Kanpur | Nepal

    Facts of Medicines

    Asciminib Tablets 40 mg

    STORAGE AND HANDLING

    Care should be exercised in the handling of ABAMUNE. ABAMUNE tablets should not be opened or crushed. Store permitted between 20-25°C (68-77°F).

    DOSAGE

    The recommended dose of SCEMBLIX is 80 mg taken orally once daily at approximately the same time each day or 40 mg twice daily at approximately 12-hour intervals. The recommended dose of SCEMBLIX is taken orally without food. Avoid food consumption for at least 2 hours before and 1 hour after taking SCEMBLIX

    SIDE EFFECTS

    The following clinically significant adverse reactions can occur with SCEMBLIX : Cardiovascular Toxicity,Myelosuppression, Hypersensitivity, Hypertension, Pancreatic Toxicity.

    WARNINGS AND PRECAUTIONS

    • Genetic testing should be indicated in order to detect whether a person is at higher risk of developing hypersensitivity.
    • Asciminib may not be added as a single agent when antiretroviral regimens are changed because of loss of the virologic response.
    • Patients with liver disease should be watchful and cautious in order to Asciminib because it can aggravate the condition.
    • In patients with Asciminib, conditions like immune reconstitution inflammatory syndrome, a change in body fat as well as an increased risk of heart attack may occur.
    • Asciminib is not recommended for use in infants who are under 3 months of age.
    • Cases like lactic acidosis and severe hepatomegaly with steatosis occurred with the use of nucleoside analogues.
    • Sometimes serious hypersensitivity reactions have been associated with Asciminib.

    FAQs – Medicine Questions

    Asciminib Tablets 40 mg
    What is Scemblix?
    Indication. SCEMBLIX® (asciminib) tablets is a prescription medicine used to treat adults with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP), previously treated with 2 or more tyrosine kinase inhibitor (TKI) medicines.
    Is Asciminib FDA approved?
    On October 29, 2021, the FDA granted accelerated approval to asciminib (brand name Scemblix) for patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase, previously treated with two or more tyrosine kinase inhibitors, and approved asciminib for adult patients with Philadelphia 
    Is TKIs chemotherapy?
    Any drug used to treat cancer (including tyrosine kinase inhibitors or TKIs) can be considered chemo, but here chemo is used to mean treatment with conventional cytotoxic (cell-killing) drugs that mainly kill cells that are growing and dividing rapidly. Chemo was once one of the main treatments for CML.
    Where can I buy Asciminib Tablets?

    You can buy Asciminib Tablets from any authorized whole-seller after getting a prescription from a qualified doctor. It is always better to check the credential of the whole-seller/supplier/exporter before buying the product.

    The buyer should check the existing law in their home country before importing the product.

    What is the procedure to buy Asciminib Tablets?

    Patients can simply fill the order form or can send mail at info@lucknowpharma.com Patients can also send WhatsApp messages to +91-9555306364 We will reply ASAP with the details of the Asciminib Tablets price as well as procurement procedure.

    Note:- The order will be confirmed only after the receipt of the Valid prescription of the Clinician.

    How do you pronounce Scemblix?
    Scemblix® (pronounced: Sem-blix) (asciminib) introduces a novel mechanism of action to the treatment of Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase (Ph+ CML-CP).

    NEWS / UPDATES